CCCC vs GL · rev $35.6M vs P/E 10, $10.26B cap
C4 Therapeutics Inc (CCCC) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
GL does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the CCCC and GL stock pages for the full models.
Not investment advice.